Mesenchymal stem cells in osteoarticular pediatric diseases: an update.

German A. Norambuena*, Maroun Khoury, Christian Jorgensen

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations


Cellular therapy has gained an increasing popularity in recent years. Mesenchymal stem cells (MSCs) have the potential to differentiate into bone, cartilage, or fat tissue. In recent studies, these cells have also shown healing capability by improving angiogenesis and preventing fibrosis, which could have a role in tissue repair and tissue regeneration. Preclinical and clinical orthopedic studies conducted in the adult population support the use of MSCs for bone-healing problems, early stages of osteonecrosis, and local bone defects. Only a few published studies support the use of MSCs in pediatric osteoarticular disorders, probably due to the unknown long-term results of cellular therapy. The purpose of this review is to explain the mechanism by which MSCs could exhibit a therapeutic role in pediatric osteoarticular disorders.

Original languageEnglish
Pages (from-to)452-458
Number of pages7
JournalPediatric Research
Issue number4 Pt 2
StatePublished - Apr 2012


Dive into the research topics of 'Mesenchymal stem cells in osteoarticular pediatric diseases: an update.'. Together they form a unique fingerprint.

Cite this